Cg Oncology Operating Income

Cg Oncology (CGON) currently reports a operating income of $-250M as of June 2026. That compares with $-160M in the prior-year period — down 60.6% year over year. Use the charts on this page to explore Cg Oncology's operating income history and peer comparisons.

Cg Oncology's operating income decreased from $-160M to $-250M — a 60.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cg Oncology reported $-250M in operating income as of June 2026. That compares with $-160M in the prior-year period — down 60.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cg Oncology, and consider following CGON for alerts when major investors trade the stock.